No Fees Unless We Win
(310) 207-3233
Menu

Medicare and Medicaid Fraud

Medicare is a government healthcare program that provides coverage to people age 65 or older. Medicaid is a partnership between the federal government and the states that provides health coverage to families and individuals with low incomes and limited resources. Medicaid, and to a certain extent Medicare, are designed to encourage doctors to help patients in need that may not have the means to pay for medical services.

Medicare and Medicaid fraud schemes can vary widely in their scope and complexity. Regardless of how it is perpetrated, fraud against government healthcare programs compromises the integrity of these programs by stealing taxpayer dollars, and can increase the cost of healthcare to everyone.

It should be noted that the prosecution of Medicare and Medicaid fraud under the False Claims Act does not require a specific intent to defraud – deliberate ignorance or disregard for the truth or falsity of information related to a claim can make the provider liable under the law.

Medicare and Medicaid fraud costs taxpayers billions every year, and a number of factors make it difficult to reign in healthcare fraud. Healthcare providers depend upon the government to pay their claims quickly so they can continue to treat Medicare and Medicaid beneficiaries. In order to increase efficiency, claims are processed and paid electronically.

The enormous amount of money changing hands every day, coupled with the need to process an enormous number of claims quickly, make Medicaid and Medicare vulnerable to fraud and abuse.

Examples of Medicare and Medicaid Fraud

Medicaid and Medicare fraud take many forms. The following settlements illustrate the broad nature of Medicare and Medicaid fraud and the important role that the whistleblower plays in exposing FCA violations.

  • Rite Aid Corporation paid $2.99 million to resolve allegations that it violated the False Claims Act by using gift cards to induce Medicare and Medicaid beneficiaries to transfer their prescriptions to Rite Aid pharmacies. Charges in the case were originally brought by a whistleblower who filed a qui tam lawsuit. The whistleblower received a reward of over $500,000.
  • The owner of two Miami home health care centers was sentenced to prison for her role in a $74 million fraud scheme in which Medicare was billed for expensive physical therapy and home health care services that were not provided or not medically necessary.
  • The Justice Department sentenced an owner and operator of two community mental health centers in Baton Rouge, Louisiana, and a patient recruiter for a community mental health center in Houston, Texas for their involvement in a $258.5 million Medicare fraud scheme. Elderly patients in nursing homes were recruited for partial hospitalization psychiatric services they did not need or receive. Some were involuntarily committed. The owner and recruiter were ordered to pay $43.5 million and $3.2 million in restitution and sentenced to 7.5 years and 5 years in jail, respectively. A psychiatrist, who was the medical director of the Louisiana facilities and co-owner of the Texas facility, was previously sentenced to 7 years in prison and ordered to pay $43.5 million in restitution.
  • Extendicare Health Services Inc. (Extendicare), a Delaware company that operates a chain of 146 skilled nursing facilities in 11 states, agreed to pay $38 million to settle allegations that it billed Medicare and Medicaid for substandard and unnecessary nursing and rehabilitation therapy services. Two whistleblowers who exposed the fraud shared an award of over $2 million.

How Whistleblowers Can Expose Medicare and Medicaid Fraud

It is estimated that fraud and abuse accounts for roughly 10 percent of all Medicare and Medicaid expenditures annually, costing taxpayers billions and driving up the overall costs of health care. Though government resources dedicated to anti-fraud enforcement are limited, whistleblowers can increase the power and impact of those resources significantly by bringing original information of fraud and abuse to the government’s attention.

Individuals working in the healthcare industry are often in positions that give them inside information on Medicare and Medicaid fraud. The False Claims Act provides whistleblowers with powerful incentives to take action if they discover this abuse. Under the FCA, a whistleblower may receive a significant monetary award if a claim leads to a successful enforcement action. The law also protects the whistleblower from employer retaliation.

A whistleblower (or relator) may file a lawsuit on behalf of themselves and the U.S. government if they have information that suggests fraud has been or is being perpetrated against the government. Such actions are permitted under the FCA, which encourages individuals with inside knowledge of fraudulent activity to take legal action and expose fraud against the government.

If the government joins the action and recovers illegally obtained payments—either through a settlement or verdict—the whistleblower may be entitled to receive between 15 percent and 25 percent of the money recovered. Even if the government does not join the lawsuit, the whistleblower may still proceed individually and receive up to 30 percent of the amounts recovered.

The chances of a whistleblower lawsuit leading to a successful enforcement action is greatly diminished without the government’s involvement. However, whistleblowers who persevere without the government’s help are likely to be awarded more than they would have received had the government intervened.

If you are aware of Medicare or Medicaid fraud and are considering taking legal action, please contact the whistleblower team at Wisner Baum.

Get Started
Call (310) 207-3233 or fill out the form below and request a free consultation.
20,000+ Families Represented

"Wisner Baum gave exceptional attention to all aspects of the case, detailed inquiry, and tenacious overview of all the information submitted. The paralegals are efficient and diligent. I was completely surprised to find an empathic personal message to take care of my own health during the challenging time of being a full-time caretaker.*"

Mary Flores
Reviewed
on Google
Read More Reviews
Case Results
We Demand Accountability.
More Successful Results
$2.0 Billion Verdict
Personal Injury
In May of 2019, the jury in the case of Pilliod et al. v, Monsanto Company ordered the agrochemical giant to pay $2.055 billion in damages to the plaintiffs, Alva and Alberta Pilliod, a Bay Area couple in their 70s. R. Brent Wisner served as co-lead trial attorney for the Pilliods, delivering the opening and closing statements and cross-examining several of Monsanto’s experts. Wisner Baum managing shareholder, Michael Baum and attorney Pedram Esfandiary also served on the trial team in the Pilliod case. The judge later reduced their award to $87M. Monsanto appealed the Pilliod’s verdict which the California Court of Appeal for the First Appellate District denied on August 9, 2021. Monsanto then requested the California Supreme Court review the appeal’s court decision, which the court denied on Nov. 17, 2021. Monsanto (Bayer) then submitted a petition for a writ of certiorari with the U.S. Supreme Court which SCOTUS denied on June 27, 2022, allowing the final judgment of $87M to remain intact.
In May of 2019, the jury in the case of Pilliod et al. v, Monsanto Company ordered the agrochemical giant to pay $2.055 billion in damages to the plaintiffs, Alva and Alberta Pilliod, a Bay Area couple in their 70s. R. Brent Wisner served as co-lead trial attorney for the Pilliods, delivering the opening and closing statements and cross-examining several of Monsanto’s experts. Wisner Baum managing shareholder, Michael Baum and attorney Pedram Esfandiary also served on the trial team in the Pilliod case. The judge later reduced their award to $87M. Monsanto appealed the Pilliod’s verdict which the California Court of Appeal for the First Appellate District denied on August 9, 2021. Monsanto then requested the California Supreme Court review the appeal’s court decision, which the court denied on Nov. 17, 2021. Monsanto (Bayer) then submitted a petition for a writ of certiorari with the U.S. Supreme Court which SCOTUS denied on June 27, 2022, allowing the final judgment of $87M to remain intact.
Continue Reading
$2.0 Billion Verdict
Personal Injury

In May of 2019, the jury in the case of Pilliod et al. v, Monsanto Company ordered the agrochemical giant to pay $2.055 billion in damages to the plaintiffs, Alva and Alberta Pilliod, a Bay Area couple in their 70s. R. Brent Wisner served as co-lead trial attorney for the Pilliods, delivering the opening and closing statements and cross-examining several of Monsanto’s experts. Wisner Baum managing shareholder, Michael Baum and attorney Pedram Esfandiary also served on the trial team in the Pilliod case.

The judge later reduced their award to $87M. Monsanto appealed the Pilliod’s verdict which the California Court of Appeal for the First Appellate District denied on August 9, 2021. Monsanto then requested the California Supreme Court review the appeal’s court decision, which the court denied on Nov. 17, 2021. Monsanto (Bayer) then submitted a petition for a writ of certiorari with the U.S. Supreme Court which SCOTUS denied on June 27, 2022, allowing the final judgment of $87M to remain intact.

$289.2 Million Verdict
Personal Injury
$289.2 million jury verdict in Monsanto Roundup trial Wisner Baum co-represented Dewayne “Lee” Johnson in the first Roundup cancer lawsuit to proceed to trial. On Aug. 10, 2018, a San Francisco jury ordered Monsanto to pay $39.25 million in compensatory damages and $250 million in punitive damages to Mr. Johnson, a former groundskeeper who alleged exposure to Monsanto’s herbicides caused him to develop terminal non-Hodgkin lymphoma. Months after the jury verdict, the judge overseeing the trial reduced the punitive damages to $39.25 million. Mr. Johnson decided to accept the remittitur, bringing the adjusted amount awarded to Mr. Johnson $78.5 million. Monsanto (Bayer) appealed the verdict and Johnson cross appealed. On July 20, 2020, the First Circuit Court of Appeals upheld the verdict against Monsanto but reduced Mr. Johnson’s award to $20.5 million. The company chose not to take the case to the U.S. Supreme Court, ending the litigation.
$289.2 million jury verdict in Monsanto Roundup trial Wisner Baum co-represented Dewayne “Lee” Johnson in the first Roundup cancer lawsuit to proceed to trial. On Aug. 10, 2018, a San Francisco jury ordered Monsanto to pay $39.25 million in compensatory damages and $250 million in punitive damages to Mr. Johnson, a former groundskeeper who alleged exposure to Monsanto’s herbicides caused him to develop terminal non-Hodgkin lymphoma. Months after the jury verdict, the judge overseeing the trial reduced the punitive damages to $39.25 million. Mr. Johnson decided to accept the remittitur, bringing the adjusted amount awarded to Mr. Johnson $78.5 million. Monsanto (Bayer) appealed the verdict and Johnson cross appealed. On July 20, 2020, the First Circuit Court of Appeals upheld the verdict against Monsanto but reduced Mr. Johnson’s award to $20.5 million. The company chose not to take the case to the U.S. Supreme Court, ending the litigation.
Continue Reading
$289.2 Million Verdict
Personal Injury

$289.2 million jury verdict in Monsanto Roundup trial

Wisner Baum co-represented Dewayne “Lee” Johnson in the first Roundup cancer lawsuit to proceed to trial. On Aug. 10, 2018, a San Francisco jury ordered Monsanto to pay $39.25 million in compensatory damages and $250 million in punitive damages to Mr. Johnson, a former groundskeeper who alleged exposure to Monsanto’s herbicides caused him to develop terminal non-Hodgkin lymphoma.

Months after the jury verdict, the judge overseeing the trial reduced the punitive damages to $39.25 million. Mr. Johnson decided to accept the remittitur, bringing the adjusted amount awarded to Mr. Johnson $78.5 million.

Monsanto (Bayer) appealed the verdict and Johnson cross appealed. On July 20, 2020, the First Circuit Court of Appeals upheld the verdict against Monsanto but reduced Mr. Johnson’s award to $20.5 million. The company chose not to take the case to the U.S. Supreme Court, ending the litigation.

$265 Million Settlement
Fatal Train Crash
In 2016, Wisner Baum attorney Timothy A. Loranger and six other attorneys in the Plaintiffs’ Management Committee were able to secure a $265 million settlement for victims of the 2015 Amtrak 188 derailment in Philadelphia, one of the largest in the U.S. for 2016.
In 2016, Wisner Baum attorney Timothy A. Loranger and six other attorneys in the Plaintiffs’ Management Committee were able to secure a $265 million settlement for victims of the 2015 Amtrak 188 derailment in Philadelphia, one of the largest in the U.S. for 2016.
Continue Reading
$265 Million Settlement
Fatal Train Crash

In 2016, Wisner Baum attorney Timothy A. Loranger and six other attorneys in the Plaintiffs’ Management Committee were able to secure a $265 million settlement for victims of the 2015 Amtrak 188 derailment in Philadelphia, one of the largest in the U.S. for 2016.

When companies choose profit over people, we fight. Wisner Baum exposes injustice, demands accountability, and delivers real results for real people. Your Path to Justice Starts Here.
Los Angeles
11111 Santa Monica
Blvd Suite 1750
Los Angeles, CA 90025
Get Directions
Bay Area
100 Drakes Landing Road
Suite 160
Greenbrae, CA 94904
Get Directions
Washington, D.C.
2101 L St NW 

Suite 800
Washington, DC 20037
Get Directions
Los Angeles
11111 Santa Monica
Blvd Suite 1750
Los Angeles, CA 90025
Get Directions
Bay Area
100 Drakes Landing Road
Suite 160
Greenbrae, CA 9490412
Get Directions
Washington, D.C.
2101 L St NW 

Suite 800
Washington, DC 20037
Get Directions
The information on this website is for general information purposes only. Nothing on this site should be taken as advice for any individual case or situation. This information is not intended to create, and receipt or viewing does not constitute a client relationship.
Send Us Your Case Details
We’ll respond and let you know the best way to proceed with your case.
crossarrow-up linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram